bell
The current prices are delayed by 15 mins, login to check live prices.
Zim Laboratories Ltd share price logo

Zim Laboratories Ltd

(ZIMLAB)

₹108.772.24%

as on 04:01PM, 20 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Zim Laboratories Ltd Performance

  • Day's Low

    Day's High

    ₹108.26
    Day's Price Range
    ₹112.5
  • 52 Week's Low

    52 Week's High

    ₹89.5
    52-Week Price Range
    ₹131.4
1 Month Return+ 7.96 %
3 Month Return+ 1.43 %
1 Year Return-7.05 %
Previous Close₹111.26
Open₹111.26
Volume1.07L
Upper Circuit-
Lower Circuit-
Market Cap₹546.31Cr

Zim Laboratories Ltd Key Statistics

P/E Ratio33.61
PEG Ratio-80.03
Market Cap₹546.31 Cr
P/B Ratio2.01
EPS3.54
Dividend Yield0
SectorPharmaceuticals
ROE7.87

Zim Laboratories Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹546.31 Cr17.12%0.66₹17 Cr₹367 Cr
NA₹435.76 Cr272.24%0.54₹28 Cr₹601 Cr
NA₹15.41 Cr278.33%0.50NANA
BUY₹23,100.09 Cr3.59%0.52NANA
NA₹706.49 Cr-0.07%0.57₹9 Cr₹179 Cr

About Zim Laboratories Ltd

Zim Laboratories Ltd is a publicly-listed major player in India's pharmaceutical industry, working in the fields of antibiotics, antibacterials, analgesics, and more. The company was incorporated in Maharashtra in 1998, and quickly began business production. While the industry is dominated by multinationals and large Indian companies, Zim Laboratories come in as a strong presence in the lower end of the market; primarily, small-scale industrial (SSI) sector. This company provides customers with a vast range of branded and generic drugs of the highest standards.

Share Price: ₹108.77 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹546.31Cr as of today
Revenue: ₹92.14Cr as on September 2024 (Q3 24)
Net Profit: ₹2.38Cr as on September 2024 (Q3 24)
Listing date: 25 Nov, 2022
Chairperson Name: Anwar S Daud
OrganisationZim Laboratories Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Zim Laboratories Ltd

  • Zim Laboratories Reports Decrease in Revenue and Net Income - 12 Jun, 2024

    Zim Laboratories reported a 7.8% decrease in revenue, with net income down by 29% and profit margin decreasing from 6.1% to 4.7% in FY 2024. EPS also decreased from ₹5.02 to ₹3.54. The Outside India segment contributed 78% of total revenue. Zim Laboratories shares are up 7.0% from a week ago.
  • ZIM Laboratories' Accrual Ratio Indicates Lower Free Cash Flow - 21 May, 2024

    An article suggests that ZIM Laboratories' free cash flow was significantly lower than its statutory profit, with a negative free cash flow of ₹576m over the last year. The company's earnings per share have grown impressively in the last three years, but investors are advised to analyze risks and warnings before investing.
  • ZIM Lab Reports Increase in Net Sales and Quarterly Net Profit - 17 May, 2024

    ZIM Lab's standalone net sales for March 2024 increased by 12.39% YoY, with a quarterly net profit of Rs. 7.89 crore, up 10.51% from the previous year. The company's EPS has also increased to Rs. 1.62 in March 2024. However, ZIM Lab shares have given negative returns of -5.65% over the last six months.

Insights on Zim Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 82.82 Cr → 93.46 Cr (in ₹), with an average increase of 11.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 0.9 Cr → 2.38 Cr (in ₹), with an average increase of 62.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 138.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 57.1% return, outperforming this stock by 62.8%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 66.63% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 33.26% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ZIMLAB stock has moved down by -2.4%

Zim Laboratories Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹85.83Cr (-)₹96.29Cr (↑12.19%)₹117.86Cr (↑22.40%)₹81.82Cr (↓30.58%)₹92.14Cr (↑12.61%)
Net Income₹4.15Cr (-)₹4.78Cr (↑15.18%)₹8.09Cr (↑69.25%)₹0.90Cr (↓88.88%)₹2.38Cr (↑164.44%)
Net Profit Margin4.84% (-)4.96% (↑2.48%)6.86% (↑38.31%)1.10% (↓83.97%)2.58% (↑134.55%)
Value in ₹ crore
Details2021202220232024
Total Assets₹329.20Cr (-)₹344.58Cr (↑4.67%)₹339.09Cr (↓1.59%)₹443.72Cr (↑30.86%)
Total Liabilities₹172.15Cr (-)₹174.48Cr (↑1.35%)₹144.91Cr (↓16.95%)₹211.76Cr (↑46.13%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹21.29Cr (-)₹31.90Cr (↑49.84%)₹47.03Cr (↑47.43%)₹35.23Cr (↓25.09%)₹11.47Cr (↓67.44%)

Zim Laboratories Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
33.26%
0.00
Foreign Institutions
0%
33.33
Mutual Funds
0%
0.00
Retail Investors
66.63%
0.01
Others
0.1%
-4.29

Zim Laboratories Ltd Key Indicators

Details20202021202220232024
Return On Equity %1.155.847.9513.737.87
Details20202021202220232024
Return On Assets %0.992.224.227.23.89
Details20202021202220232024
Book Value Per Share (₹)31.6932.9936.0641.1249
Details20202021202220232024
Earning Per Share (₹)0.681.52.995.013.54

Zim Laboratories Ltd Valuation

Zim Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.12x)

June 11, 2018

Today (33.61x)

December 19, 2024

Industry (56.23x)

December 19, 2024

Highest (198.80x)

July 1, 2021

LowHigh

Zim Laboratories Ltd Earnings and Dividends

  • Zim Laboratories Ltd Earnings Results

    Zim Laboratories Ltd’s net profit fell -42.65% since last year same period to ₹2.38Cr in the Q2 2024-2025. On a quarterly growth basis, Zim Laboratories Ltd has generated 164.44% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Zim Laboratories Ltd Dividends May,2019

    In the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.38%.

    Read More about Dividends

Zim Laboratories Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Zim Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Zim Laboratories Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Zim Laboratories Ltd shares.

Zim Laboratories Ltd (ZIMLAB) share price today is ₹108.77

Zim Laboratories Ltd is listed on NSE

Zim Laboratories Ltd is listed on BSE

  • Today’s highest price of Zim Laboratories Ltd is ₹112.5.
  • Today’s lowest price of Zim Laboratories Ltd is ₹108.26.

PE Ratio of Zim Laboratories Ltd is 33.61

PE ratio = Zim Laboratories Ltd Market price per share / Zim Laboratories Ltd Earnings per share

Today’s traded volume of Zim Laboratories Ltd(ZIMLAB) is 1.07L.

Today’s market capitalisation of Zim Laboratories Ltd(ZIMLAB) is ₹546.31Cr.

Zim Laboratories Ltd(ZIMLABPrice
52 Week High
₹131.4
52 Week Low
₹89.5

Zim Laboratories Ltd(ZIMLAB) share price is ₹108.77. It is down -17.22% from its 52 Week High price of ₹131.4

Zim Laboratories Ltd(ZIMLAB) share price is ₹108.77. It is up 21.53% from its 52 Week Low price of ₹89.5

Zim Laboratories Ltd(ZIMLABReturns
1 Day Returns
-2.49%
1 Month Returns
7.96%
3 Month Returns
1.43%
1 Year Returns
-7.05%